OCT for glaucoma: Today and tomorrow

Article

Comprehensive analysis helps with diagnosis and follow-up

Spectral-domain optical coherence tomography (SD-OCT) is now an established diagnostic tool for optic nerve diseases such as glaucoma. Since the first studies on glaucomatous eyes were published a decade ago using time-domain OCT (TD-OCT), remarkable advances have been realized.

Today ophthalmologists can use SD-OCT to investigate several parameters in cases with any degree of glaucoma. These are derived from the peripapillary retinal nerve fibre layer (RNFL), the optic nerve head (ONH) and the macular ganglion cells (GC). Comprehensive analysis of these data help the clinician in making the diagnosis and following patients up.

Peripapillary RNFL

Given the already good diagnostic capabilities of TD-OCT, it is not surprising that most studies performed with SD-OCT failed to detect any significant improvement when conventional circular peripapillary scans are used.1–4 The main advantage of SD-OCT is rather the remarkably improved repeatability of RNFL thickness measurements in both healthy and glaucomatous eyes, as shown by a test-retest variability which is half compared to that of TD-OCT.1,5 The main reason for such an improvement is related to the new acquisition protocols.

In the case of Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, California, USA), for example, the instrument does not just scan a circle around the ONH, but provides a tridimensional cube of peripapillary data; the 3.4 mm circular scan is subsequently extracted once the centre of the disc is automatically identified, so that the circle is automatically centred. By doing so the operator reduces the measurement variability typical of TD-OCT, where scan repeatability is strongly influenced by improper location of the circle around the ONH.6

It is important to highlight that the instruments manufactured by the different companies provide different, non-interchangeable measurements. Although only a few studies have directly compared some of these instruments,7,8 the published values clearly show that the algorithms developed by each manufacturer to identify and quantify the RNFL thickness are different. The 360° peripapillary RNFL thickness ranges between 89.8 and 113 microns.1,7–16 None of these measurements are interchangeable with those obtained by TD-OCT.

Compared to TD-OCT, one the main advancements of SD-OCT is represented by the RNFL thickness deviation map, which provides additional spatial and morphologic information about RNFL damage and improves the diagnostic sensitivity for glaucoma detection. Recent studies have demonstrated that the above-mentioned map has significantly higher value for diagnostic purposes compared to the standard circular scan.21,22

Last generation SD-OCT devices also offer the advantage of specifically designed software to assess glaucoma progression.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.